These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 36251624)
1. Neutrophils as drivers of vascular injury in sickle cell disease. Torres LS; Hidalgo A Immunol Rev; 2023 Mar; 314(1):302-312. PubMed ID: 36251624 [TBL] [Abstract][Full Text] [Related]
2. Patrolling monocytes scavenge endothelial-adherent sickle RBCs: a novel mechanism of inhibition of vaso-occlusion in SCD. Liu Y; Zhong H; Bao W; Mendelson A; An X; Shi P; Chou ST; Manwani D; Yazdanbakhsh K Blood; 2019 Aug; 134(7):579-590. PubMed ID: 31076443 [TBL] [Abstract][Full Text] [Related]
3. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyte-endothelium interactions and NF-ĸB activation in transgenic sickle mice. Belcher JD; Chen C; Nguyen J; Abdulla F; Nguyen P; Nguyen M; Okeley NM; Benjamin DR; Senter PD; Vercellotti GM PLoS One; 2015; 10(2):e0117772. PubMed ID: 25706118 [TBL] [Abstract][Full Text] [Related]
5. The Red Blood Cell-Inflammation Vicious Circle in Sickle Cell Disease. Nader E; Romana M; Connes P Front Immunol; 2020; 11():454. PubMed ID: 32231672 [TBL] [Abstract][Full Text] [Related]
6. HO-1 Liu Y; Jing F; Yi W; Mendelson A; Shi P; Walsh R; Friedman DF; Minniti C; Manwani D; Chou ST; Yazdanbakhsh K Blood; 2018 Apr; 131(14):1600-1610. PubMed ID: 29437594 [TBL] [Abstract][Full Text] [Related]
7. Vasculopathy in Sickle Cell Disease: From Red Blood Cell Sickling to Vascular Dysfunction. Nader E; Conran N; Romana M; Connes P Compr Physiol; 2021 Apr; 11(2):1785-1803. PubMed ID: 33792905 [TBL] [Abstract][Full Text] [Related]
13. Genetic diminution of circulating prothrombin ameliorates multiorgan pathologies in sickle cell disease mice. Arumugam PI; Mullins ES; Shanmukhappa SK; Monia BP; Loberg A; Shaw MA; Rizvi T; Wansapura J; Degen JL; Malik P Blood; 2015 Oct; 126(15):1844-55. PubMed ID: 26286849 [TBL] [Abstract][Full Text] [Related]
14. Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease. Li H; Kazmi JS; Lee S; Zhang D; Gao X; Maryanovich M; Torres L; Verma D; Kelly L; Ginzburg YZ; Frenette PS; Manwani D Blood; 2023 Jan; 141(2):194-199. PubMed ID: 36315910 [TBL] [Abstract][Full Text] [Related]
15. Dynamics of von Willebrand factor reactivity in sickle cell disease during vaso-occlusive crisis and steady state. Sins JWR; Schimmel M; Luken BM; Nur E; Zeerleder SS; van Tuijn CFJ; Brandjes DPM; Kopatz WF; Urbanus RT; Meijers JCM; Biemond BJ; Fijnvandraat K J Thromb Haemost; 2017 Jul; 15(7):1392-1402. PubMed ID: 28457019 [TBL] [Abstract][Full Text] [Related]
16. Sickle cell disease as a vascular disorder. Ofori-Acquah SF Expert Rev Hematol; 2020 Jun; 13(6):645-653. PubMed ID: 32362160 [TBL] [Abstract][Full Text] [Related]
18. Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease. Tchernychev B; Li H; Lee SK; Gao X; Ramanarasimhaiah R; Liu G; Hall KC; Bernier SG; Jones JE; Feil S; Feil R; Buys ES; Graul RM; Frenette PS; Masferrer JL Br J Pharmacol; 2021 Sep; 178(17):3463-3475. PubMed ID: 33864386 [TBL] [Abstract][Full Text] [Related]
19. Sevuparin binds to multiple adhesive ligands and reduces sickle red blood cell-induced vaso-occlusion. Telen MJ; Batchvarova M; Shan S; Bovee-Geurts PH; Zennadi R; Leitgeb A; Brock R; Lindgren M Br J Haematol; 2016 Dec; 175(5):935-948. PubMed ID: 27549988 [TBL] [Abstract][Full Text] [Related]
20. Sickle cell vaso-occlusion: The dialectic between red cells and white cells. Conran N; Embury SH Exp Biol Med (Maywood); 2021 Jun; 246(12):1458-1472. PubMed ID: 33794696 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]